The Director General of the Agence de la biomédecine shall authorise the import and export of embryonic stem cells for research purposes, after obtaining the opinion of the Steering Committee. This authorisation is valid for two years.
This authorisation is issued for each operation envisaged.
The provisions of articles R. 2151-6, R. 2151-9, R. 2151-10 and R. 2151-12 apply to the authorisations provided for in this section.